"
Team:British Columbia/Human Practices
From 2012.igem.org
Contents |
Intellectual Property
- Ask UBC [http://www.uilo.ubc.ca tech transfer office]
- Mike Gold suggested dropping his name to Ian Bell, Technology Transfer Manager for the Life Sciences
- Dr. Andre Marziali, EngPhys Director
- OSLI guidance?
- [http://biobricks.org/bpa/faq/ biobrick agreement]
- [1]
- investigate online survey mechanism
Previous iGEM work
Survey questions for iGEM
The 2012 UBC team is planning on making a FAQ to help iGEMers better understand intellectual property (IP) and how it is concerns us . We're hoping your iGEM team would like to collaborate with us by answering some survey questions and sharing your experiences. IP, according to the Canadian Intellectual Property Office, are "legal rights that result from intellectual activity in the industrial, scientific, literary, and artistic fields" [http://www.cipo.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr00011.html [1]]. This can come in the forms such as patents, copyrights, trademarks, and trade secrets. Copyrights give creators of original, dramatic, artistic, musical, and literary works exclusive rights to use them [http://www.cipo.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr00003.html?OpenDocument [2]]. These are applicable to computer programs. Patents, on the other hand, are the "right[s], granted by government, to exclude others from making, using, or selling your invention" [http://www.cipo.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr00001.html [3]]. To qualify for a patent, the idea must fufill certain criteria:
- Utility: The invention must do what you claim it to do
- Novelty: The idea must be unique and not previously mentioned in any literature
- Non-obviousness: The invention must not be of something that can easily be thought up by non-experts
- Material Patentability: The subject matter must be considered patentable by the government issuing the patent
Our FAQ will focus mainly on patents, how it relates to iGEM projects, and how it affects the usage of the BioBrick registry.
- What experiences have you had with IP in iGEM?
- How did you approach the process?
- What resources did you use? Do you know how to find resources?
- What issues did you encounter?
- Have you consulted anyone outside of your team about IP?
- What would you like to have done to improve your experience?
- Do you have experience outside of iGEM?
- Has IP concerns affected your project? If so, how?
- What do you want to know about IP that we can help you with?
- Are you worried about the IP aspect of your project?
- Would you be interested in a FAQ about IP for iGEM?
- What type of format would you prefer? (e.g., video, FAQ page, "Choose your own adventure" walkthrough, etc.)
- Are you interested in protecting our own IP (e.g., through patenting)?
- Do you think Biobricks can be patented?
- Do you think iGEM teams can produce patentable projects?
- Do you think you can take your patent country to country easily?
- How much do you think patenting something costs?
- How much time do you think the patenting process would take?
- What is your main IP concern: Use of existing patents or establishing ownership of new patents?
- Do you know if your team's project depends on anything that is protected by IP rights?
- Do you think this would get in the way for patenting your own project?
- What aspect of dealing with IP would you like the most help with? What would you like to get out of a FAQ?
- How do you think IP protection affects innovation?
- Do you think IP protection and open source ideals can coexist?
- How does IP help/hurt your project?
Questions for Professionals
- What's a good rule of thumb for determining what things in biotechnology be patentable?
- Does that strongly vary among jurisdiction?
- What are particularly difficult jurisdictions to get patents in?
- What pitfalls might an iGEM team run into?
- Do you think it's worthwhile for iGEM teams to explore patenting for their projects? (ask Randy Retberg/iGEM HQ too)
- How do you think IP protection affects innovation?
- Is it generally worth getting a patent in just one country?
- How does the industry approach/handle patents held by researchers?
- How does IP help/hurt your project?
- How do you decide if something is worth patenting/licensing?
- What are the university's policies concerning ownership of researchers' work? How are they generally compared to other universities?
- How does the UILO/TTO help researchers reach their goals in getting IP protection?
- What happens when someone infringes a patent?
- What happens when someone doesn't give the university ownership of the IP? For example, if the researcher claims that he/she worked on it on their own time or at another institution?
- How does company sponsorship affect IP ownership?
- What are some typical problems researchers encounter?
Community Outreach
US/Canada Regulatory Concerns
- illegitimate DNA transfer (strains on band-aids in magazines?)
OSLI feedback
- Biosafety
- Efficiency
- Environmental
